Bharat Biotech

Covid nasal vaccine's phase 3 trials completed: Bharat Biotech chief
Covaxin safe for children aged 2-18 years, says Bharat Biotech
DCGI gives emergency use authorisation to Covaxin for 6-12 age group
SII to give free Covishield vials to pvt vaccination centres to compensate for price difference
SII, Bharat Biotech cut Covid vaccine prices for private hospitals to Rs 225
WHO said nothing related to efficacy: Bharat Biotech on Covaxin
Read More
DT next
www.dtnext.in